PI 3-kinase p85β shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingMolecular oncologyNovember 1, 2021Di Paolo D, Pontis F, Moro M, Centonze G, Bertolini G, Milione M, Mensah M, Segale M, Petraroia I, Borzi C, et al.

(2) LncRNA AK023948 is a positive regulator of AKTNature communicationsFebruary 8, 2017Koirala P, Huang J, Ho TT, Wu F, Ding X, Mo YY.

(3) MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell LinesFrontiers in geneticsJanuary 1, 2016Meng F, Wang F, Wang L, Wong SC, Cho WC, Chan LW.RIPA lysis and extraction buffer (#89900) used to lyse cells was purchased from ThermoFisher. PIK3R2-shRNA (#sc-39125-SH) and the Control shRNA Plasmid-A (#sc-108060) were purchased from Santa Cruz Biotechnology. MiR-30a-5p

(5) Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genesFrontiers in microbiologyJanuary 1, 2015Tian J, Zhang X, Wu H, Liu C, Li Z, Hu X, Su S, Wang LF, Qu L.

PI 3-kinase p85β shRNA Plasmid (h)